XML 84 R67.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation Plans - Schedule of Stock-Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2020
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Options Outstanding and Available for Grant          
Transferred to 2021 Plan (in shares)     (450,000)    
Weighted-Average Exercise Price Per Share          
Options granted (in dollars per share)     $ 6.66 $ 1.72 $ 1.38
2010 Plan          
Options Outstanding and Available for Grant          
Options outstanding, beginning balance (in shares)     19,440,000   22,775,000
Options granted (in shares) 3,588,535 924,000      
Options exercised (in shares)   (3,480,000)      
Options forfeited (in shares)   172,000      
Options expired (in shares)   (779,000)      
Options outstanding, ending balance (in shares)     19,440,000   22,775,000
Options outstanding and exercisable (in shares)     11,434,000    
Weighted-Average Exercise Price Per Share          
Beginning balance (in dollars per share)     $ 2,060.00 1.81  
Options granted (in dollars per share) $ 2.05   6,540    
Options exercised (in dollars per share)     1,510    
Options forfeited and expired (in dollars per share)     2,570    
Ending balance (in dollars per share)     2,060.00 $ 1.81  
Options outstanding and exercisable (in dollars per share)     $ 1,810    
Weighted-Average Remaining Contractual Life (years)          
Options outstanding (years)     6 years 3 months 14 days 7 years 4 months 9 days  
Options outstanding and exercisable (in shares)     5 years 3 months 7 days    
Aggregate Intrinsic Value (in thousands)          
Options outstanding     $ 208,042 $ 107,696  
Options outstanding and exercisable     $ 125,242    
Outstanding stock options | 2010 Plan          
Options Outstanding and Available for Grant          
Options available for grant, beginning balance (in shares)       202,000  
Options authorized (in shares)   1,000,000 1,000,000 6,500,000  
Options available for grant, ending balance (in shares)     0   202,000